{ }
001122334455554433221100
001122334455554433221100

analysts predict significant gains for crisper therapeutics amid challenges ahead

Wall Street analysts are optimistic about CRISPR Therapeutics, projecting potential gains of 114% to 152% by 2025, driven by its gene therapy Casgevy and promising trial results for CTX112, a treatment for blood cancers. However, slow sales of Casgevy and significant operational losses raise concerns about the company's financial stability. Investors should weigh the high risks against potential rewards before committing funds.

biotech stock poised for significant gains amid challenges in treatment sales

Wall Street analysts are optimistic about CRISPR Therapeutics, projecting potential gains of 114% to 152% in 2025, driven by its gene therapy, Casgevy, which recently received FDA approval for treating sickle cell disease and beta-thalassemia. However, despite the promising technology, the company faces challenges in generating sales and manufacturing personalized treatments. Analysts have adjusted price targets, with one lowering it to $85 while maintaining a buy rating, and another setting a target of $100.

Machinary offers a groundbreaking, modular, and customizable solution that provides advanced financial news and statistical analysis. Our platform goes beyond traditional quantitative analysis, offering users a comprehensive understanding of real-time market dynamics, event detection, and risk analysis.

Address

Newsletter

© 2025 by Machinary.com - Version: 1.0.0.0. All rights reserved

Layout

Color mode

Theme mode

Layout settings

Seems like the connection with the server has been lost. It can be due to poor or broken network. Please hang on while we're trying to reconnect...
Oh snap! Failed to reconnect with the server. This is typically caused by a longer network outage, or if the server has been taken down. You can try to reconnect, but if that does not work, you need to reload the page.
Oh man! The server rejected the attempt to reconnect. The only option now is to reload the page, but be prepared that it won't work, since this is typically caused by a failure on the server.